Oncolibrary

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Oncolibrary
Apr 6, 2025, 07:01 | Cancer Types
Bladder Cancer Treatment: The Game-Changing Role of Antibody-Drug Conjugates (ADCs)
Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of…
Apr 6, 2025, 01:44 | Immune Oncology
Immunotherapy for Skin Cancer: Types, Success Rate, Side Effects and More
Immunotherapy has become a powerful treatment option for skin cancer, especially for melanoma and certain…
Apr 5, 2025, 14:11 | Immune Oncology
How Long Does Immunotherapy Stay in Your System?
Immunotherapy has become a major breakthrough in cancer treatment, helping the body’s own immune system…
Apr 5, 2025, 06:19 | Cancer Types
Neuroendocrine Tumors: The Silent Cancer on the Rise – Breakthroughs in Diagnosis, Treatment, Survival and Latest 2025 Reaserches
Neuroendocrine tumors (NETs) are a rare type of cancer that arises from specialized cells of…
Apr 4, 2025, 13:58 | Oncolibrary
New Paper Alert: SMART ONE Trial: Single Fraction MR-Guided SBRT for Visceral Tumors
The SMART ONE trial is the first prospective study to evaluate the feasibility, safety, and…
Apr 4, 2025, 12:51 | Oncolibrary
New Paper Alert: Reduced-Dose Apixaban Found Effective for Extended Treatment of Cancer-Associated VTE
The evolving landscape of oncology, managing cancer-associated venous thromboembolism (VTE) remains a delicate balance between…
Mar 31, 2025, 13:15 | Oncolibrary
FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer
On March 28, 2025, the U.S. Food and Drug Administration (FDA) expanded the approval of…
Mar 31, 2025, 12:26 | Oncolibrary
New Paper Alert: Low-dose CT for lung cancer screening in a high-risk population (SUMMIT study)
The SUMMIT study provides compelling evidence for the feasibility and effectiveness of large-scale lung cancer…
Mar 31, 2025, 11:22 | Oncolibrary
New Paper Alert: KEYNOTE-921 Trial of Pembrolizumab Plus Docetaxel VS Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer
Metastatic castration-resistant prostate cancer (mCRPC) remains a major therapeutic challenge, particularly after disease progression on…
Mar 30, 2025, 14:01 | Cancer Types
Melanoma (Skin Cancer): Symptoms, Causes, Stages, Diagnosis and Treatment
Skin cancer is one of the most common forms of cancer worldwide, with melanoma being…
All: 340 Posts: 141 - 150
Special Coverage